JP2013545785A5 - - Google Patents

Download PDF

Info

Publication number
JP2013545785A5
JP2013545785A5 JP2013543799A JP2013543799A JP2013545785A5 JP 2013545785 A5 JP2013545785 A5 JP 2013545785A5 JP 2013543799 A JP2013543799 A JP 2013543799A JP 2013543799 A JP2013543799 A JP 2013543799A JP 2013545785 A5 JP2013545785 A5 JP 2013545785A5
Authority
JP
Japan
Prior art keywords
compound according
compound
motomeko
group
cycloalkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013543799A
Other languages
English (en)
Japanese (ja)
Other versions
JP6005656B2 (ja
JP2013545785A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2011/073008 external-priority patent/WO2012080446A1/en
Publication of JP2013545785A publication Critical patent/JP2013545785A/ja
Publication of JP2013545785A5 publication Critical patent/JP2013545785A5/ja
Application granted granted Critical
Publication of JP6005656B2 publication Critical patent/JP6005656B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2013543799A 2010-12-16 2011-12-16 ベンゾイミダゾール呼吸合胞体ウイルス阻害剤 Expired - Fee Related JP6005656B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP10195467.5 2010-12-16
EP10195467 2010-12-16
PCT/EP2011/073008 WO2012080446A1 (en) 2010-12-16 2011-12-16 Benzimidazole respiratory syncytial virus inhibitors

Publications (3)

Publication Number Publication Date
JP2013545785A JP2013545785A (ja) 2013-12-26
JP2013545785A5 true JP2013545785A5 (enExample) 2014-06-26
JP6005656B2 JP6005656B2 (ja) 2016-10-12

Family

ID=43875271

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013543799A Expired - Fee Related JP6005656B2 (ja) 2010-12-16 2011-12-16 ベンゾイミダゾール呼吸合胞体ウイルス阻害剤

Country Status (30)

Country Link
US (1) US8865705B2 (enExample)
EP (1) EP2651903B1 (enExample)
JP (1) JP6005656B2 (enExample)
KR (1) KR101876240B1 (enExample)
CN (2) CN103313974A (enExample)
AR (1) AR085203A1 (enExample)
AU (1) AU2011343255B2 (enExample)
BR (1) BR112013012137A2 (enExample)
CA (1) CA2821999C (enExample)
CL (1) CL2013001713A1 (enExample)
CY (1) CY1117751T1 (enExample)
DK (1) DK2651903T3 (enExample)
EA (1) EA022972B1 (enExample)
ES (1) ES2576180T3 (enExample)
HK (1) HK1247616A1 (enExample)
HR (1) HRP20160650T1 (enExample)
HU (1) HUE029247T2 (enExample)
IL (1) IL225640A (enExample)
MX (1) MX340030B (enExample)
MY (1) MY156641A (enExample)
NZ (1) NZ609450A (enExample)
PH (1) PH12013500796A1 (enExample)
PL (1) PL2651903T3 (enExample)
PT (1) PT2651903E (enExample)
SG (1) SG190766A1 (enExample)
SI (1) SI2651903T1 (enExample)
TW (1) TWI530495B (enExample)
UA (1) UA112298C2 (enExample)
WO (1) WO2012080446A1 (enExample)
ZA (1) ZA201304424B (enExample)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI515187B (zh) * 2010-12-16 2016-01-01 健生科學愛爾蘭無限公司 作為呼吸道融合病毒抗病毒劑之吲哚類
TWI541241B (zh) * 2010-12-16 2016-07-11 健生科學愛爾蘭無限公司 作為呼吸道融合病毒抗病毒劑之咪唑并吡啶類
TWI501967B (zh) 2010-12-16 2015-10-01 Janssen R&D Ireland 作為呼吸道融合病毒抗病毒劑之氮雜吲哚類
TWI530495B (zh) 2010-12-16 2016-04-21 健生科學愛爾蘭無限公司 苯并咪唑呼吸道融合病毒抑制劑
TWI527814B (zh) * 2010-12-16 2016-04-01 健生科學愛爾蘭無限公司 作為呼吸道融合病毒抗病毒劑之氮雜苯并咪唑類
JP2015523350A (ja) * 2012-06-15 2015-08-13 ヤンセン・アールアンドデイ・アイルランド Rsウイルス抗ウイルス薬としての、ベンゾイミダゾールによって置換された新規1,3−ジヒドロ−2h−ベンゾイミダゾル−2−オン誘導体
DK2864323T3 (en) * 2012-06-15 2017-08-14 Janssen Sciences Ireland Uc 1,3-DIHYDRO-2H-BENZIMIDAZOLE-2 UNDERIVATIVES SUBSTITUTED BY HETEROCYCLES AS ANTIVIRUS AGENTS AGAINST RESPIRATORY SYNCYTIAL VIRUS
BR112015000392A2 (pt) * 2012-07-10 2017-06-27 Hoffmann La Roche novos indazóis para o tratamento e profilaxia da infecção por vírus sincicial respiratório
TWI598351B (zh) 2012-10-16 2017-09-11 健生科學愛爾蘭無限公司 Rsv抗病毒化合物
KR102254837B1 (ko) 2013-01-28 2021-05-24 얀센 사이언시즈 아일랜드 언리미티드 컴퍼니 호흡기 합포체 바이러스의 항바이러스제로서의 퀴녹살리논 및 디하이드로퀴녹살리논
CA2910508A1 (en) 2013-05-14 2014-11-20 Song Feng Aza-oxo-indoles for the treatment and prophylaxis of respiratory syncytial virus infection
CN105392787B (zh) * 2013-05-14 2017-11-24 豪夫迈·罗氏有限公司 用于治疗和预防呼吸道合胞病毒感染的氮杂‑氧代‑吲哚
EP3033333A1 (en) * 2013-08-15 2016-06-22 F. Hoffmann-La Roche AG Novel aza-oxo-indoles for the treatment and prophylaxis of respiratory syncytial virus infection
WO2015026792A1 (en) 2013-08-21 2015-02-26 Alios Biopharma, Inc. Antiviral compounds
WO2015065336A1 (en) * 2013-10-29 2015-05-07 Medivir Ab Respiratory syncytial virus inhibitors
TWI671299B (zh) 2014-04-14 2019-09-11 愛爾蘭商健生科學愛爾蘭無限公司 作為rsv抗病毒化合物之螺脲化合物
CA2957017A1 (en) * 2014-08-05 2016-02-11 Alios Biopharma, Inc. Combination therapy for treating a paramyxovirus
MA41614A (fr) 2015-02-25 2018-01-02 Alios Biopharma Inc Composés antiviraux
SMT202200437T1 (it) 2015-07-22 2023-01-13 Enanta Pharm Inc Derivati benzodiazepinaci come inibitori del rsv
CN108699077B (zh) 2016-01-15 2021-03-02 英安塔制药有限公司 作为rsv抑制剂的杂环化合物
KR102573499B1 (ko) 2017-02-16 2023-08-31 이난타 파마슈티칼스, 인코포레이티드 벤조디아제핀 유도체의 제조 방법
WO2019006295A1 (en) 2017-06-30 2019-01-03 Enanta Pharmaceuticals, Inc. HETEROCYCLIC COMPOUNDS AS RSV INHIBITORS
JP7198811B2 (ja) 2017-09-29 2023-01-04 エナンタ ファーマシューティカルズ インコーポレイテッド Rsv阻害剤としての組み合わせ医薬剤
NZ764647A (en) 2017-11-13 2025-12-19 Enanta Pharm Inc Processes for the resolution of benzodiazepin-2-one and benzoazepin-2-one derivatives
AU2020240024B2 (en) 2019-03-18 2025-06-26 Enanta Pharmaceuticals, Inc Benzodiazepine derivatives as RSV inhibitors
CN114761016A (zh) 2019-10-04 2022-07-15 英安塔制药有限公司 抗病毒杂环化合物
US11505558B1 (en) 2019-10-04 2022-11-22 Enanta Pharmaceuticals, Inc. Antiviral heterocyclic compounds
UY39032A (es) 2020-01-24 2021-07-30 Enanta Pharm Inc Compuestos heterocíclicos como agentes antivirales
WO2021250180A1 (en) 2020-06-11 2021-12-16 Janssen Sciences Ireland Unlimited Company Hemi (l)-tartrate forms of 3-({5-chloro-1-[3-(methylsulfonyl)propyl]-1h-indol-2 yl} methyl)-1-(2,2,2-trifluoroethyl)-1,3-dihydro-2h-imidazo[4,5-c]pyridin-2-one and pharmaceutical compositions comprising the same
WO2022010882A1 (en) 2020-07-07 2022-01-13 Enanta Pharmaceuticals, Inc, Dihydroquinoxaline and dihydropyridopyrazine derivatives as rsv inhibitors
US11945824B2 (en) 2020-10-19 2024-04-02 Enanta Pharmaceuticals, Inc. Heterocyclic compounds as anti-viral agents
US11945830B2 (en) 2021-02-26 2024-04-02 Enanta Pharmaceuticals, Inc. Antiviral heterocyclic compounds
AR129003A1 (es) 2022-04-07 2024-07-03 Enanta Pharm Inc Compuestos heterocíclicos antivirales
US12162857B2 (en) 2022-04-27 2024-12-10 Enanta Pharmaceuticals, Inc. Antiviral compounds
WO2024174953A1 (zh) * 2023-02-21 2024-08-29 苏州隆博泰药业有限公司 苯并咪唑类衍生物及其医药用途

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998001428A1 (en) 1996-07-08 1998-01-15 Du Pont Pharmaceuticals Company AMIDINOINDOLES, AMIDINOAZOLES, AND ANALOGS THEREOF AS INHIBITORS OF FACTOR Xa AND OF THROMBIN
WO2000020400A1 (en) 1998-10-05 2000-04-13 Axys Pharmaceuticals, Inc. Novel compounds and compositions for treating hepatitis c infections
WO2001000612A2 (en) 1999-06-28 2001-01-04 Janssen Pharmaceutica N.V. Respiratory syncytial virus replication inhibitors
TR200600172T2 (tr) 1999-06-28 2007-10-22 Janssen Pharmaceutica N.V Solunum sistemi sinsitiyal virüsünün replikasyonunu inhibe edici maddeler.
AU6762400A (en) 1999-08-12 2001-03-13 Cor Therapeutics, Inc. Inhibitors of factor xa
US6489338B2 (en) * 2000-06-13 2002-12-03 Bristol-Myers Squibb Company Imidazopyridine and imidazopyrimidine antiviral agents
US6506738B1 (en) 2000-09-27 2003-01-14 Bristol-Myers Squibb Company Benzimidazolone antiviral agents
US6919331B2 (en) 2001-12-10 2005-07-19 Bristol-Myers Squibb Company Substituted 2-methyl-benzimidazole respiratory syncytial virus antiviral agents
US20040166137A1 (en) 2002-11-08 2004-08-26 Lackey John William Hetero-substituted benzimidazole compounds and antiviral uses thereof
TWI541241B (zh) 2010-12-16 2016-07-11 健生科學愛爾蘭無限公司 作為呼吸道融合病毒抗病毒劑之咪唑并吡啶類
TWI515187B (zh) 2010-12-16 2016-01-01 健生科學愛爾蘭無限公司 作為呼吸道融合病毒抗病毒劑之吲哚類
TWI501967B (zh) 2010-12-16 2015-10-01 Janssen R&D Ireland 作為呼吸道融合病毒抗病毒劑之氮雜吲哚類
TWI527814B (zh) 2010-12-16 2016-04-01 健生科學愛爾蘭無限公司 作為呼吸道融合病毒抗病毒劑之氮雜苯并咪唑類
TWI530495B (zh) 2010-12-16 2016-04-21 健生科學愛爾蘭無限公司 苯并咪唑呼吸道融合病毒抑制劑

Similar Documents

Publication Publication Date Title
JP2013545785A5 (enExample)
JP2014503525A5 (enExample)
RU2477723C2 (ru) Ингибиторы протеинкиназ (варианты), их применение для лечения онкологических заболеваний и фармацевтическая композиция на их основе
JP2016523955A5 (enExample)
JP2014511892A5 (enExample)
JP2015537020A5 (enExample)
JP2014506907A5 (enExample)
JP2014507455A5 (enExample)
JP2012092103A5 (enExample)
JP2013510120A5 (enExample)
JP2016503793A5 (enExample)
JP2014500861A5 (enExample)
JP2010523522A5 (enExample)
JP2016515560A5 (enExample)
JP2016518437A5 (enExample)
JP2013032389A5 (enExample)
JP2016513130A5 (enExample)
JP2013537203A5 (enExample)
JP2016518434A5 (enExample)
JP2014511891A5 (enExample)
JP2013534248A5 (enExample)
JP2013542261A5 (enExample)
EP2607363A4 (en) CONDENSED RING COMPOUND FOR USE AS MINERALOCORTICOID RECEPTOR ANTAGONISTS
JP2014500265A5 (enExample)
JP2019516739A5 (enExample)